CVS Health Corporation $CVS Stock Holdings Increased by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP grew its holdings in CVS Health Corporation (NYSE:CVS) by 334.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,043 shares of the pharmacy operator’s stock after acquiring an additional 20,044 shares during the period. Fulcrum Asset Management LLP’s holdings in CVS Health were worth $2,268,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Kilter Group LLC acquired a new stake in shares of CVS Health in the 2nd quarter valued at $27,000. Beaird Harris Wealth Management LLC boosted its holdings in CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 195 shares in the last quarter. J.Safra Asset Management Corp acquired a new position in CVS Health during the second quarter worth $30,000. Timbuktu Capital Management LLC acquired a new position in CVS Health during the second quarter worth $31,000. Finally, Dunhill Financial LLC bought a new position in CVS Health during the second quarter valued at about $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on CVS shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a $103.00 price target on shares of CVS Health in a research report on Wednesday, November 4th. Leerink Partners lowered their price objective on CVS Health from $112.00 to $104.00 and set an “outperform” rating on the stock in a report on Thursday, November 5th. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday. Robert W. Baird set a $107.00 target price on CVS Health in a report on Thursday, August 6th. Finally, Wall Street Zen cut CVS Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 19th. Twenty-three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $108.25.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Zacks upgraded CVS to Rank #2 (Buy), citing improving optimism about the company’s earnings prospects. Article: All You Need to Know About CVS Health Rating Upgrade to Buy
• Positive Sentiment: Incoming CVS Pharmacy CEO Prem Shah reportedly purchased about $2 million of CVS shares, a notable show of confidence from an executive expected to lead one of the businesses after the separation. Article: CVS Health’s Future Pharmacy CEO Just Bought $2 Million of Stock
• Neutral Sentiment: CVS has announced plans to split into two companies by 2028. The restructuring could let each business focus more clearly on its operations, but the companies’ structure and the benefits to shareholders remain important unanswered questions. Article: CVS Health Announces Plan to Split Into Two Companies
• Negative Sentiment: Analyst estimates have become more cautious as the separation plan is factored in. One fair-value estimate was trimmed from $116.28 to $113.76, with execution risk and valuation concerns weighing on the outlook. Article: CVS Health Stock Fair Value Edges Lower on Separation Risk and Analyst Caution

CVS Health Stock Up 4.4%

CVS Health stock opened at $89.03 on Wednesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The firm has a fifty day moving average price of $90.12 and a two-hundred day moving average price of $88.94. The firm has a market cap of $113.92 billion, a price-to-earnings ratio of 10.36, a P/E/G ratio of 0.74 and a beta of 0.58.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.44. The company had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The firm’s revenue was up 5.4% compared to the same quarter last year. During the same period last year, the business posted $1.60 earnings per share. As a group, analysts forecast that CVS Health Corporation will post 8.25 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a $0.6650 dividend. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.0%. CVS Health’s dividend payout ratio (DPR) is 30.97%.

Insider Activity

In related news, EVP Prem Shah bought 23,855 shares of the company’s stock in a transaction that occurred on Friday, November 6th. The shares were acquired at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the transaction, the executive vice president owned 88,516 shares of the company’s stock, valued at $7,425,607.24. The trade was a 36.89% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.85% of the company’s stock.

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.